A practical reference on lyophilized powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-09 and is reviewed periodically as new material appears.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
| Property | Value | Notes |
|---|---|---|
| Primary route studied | Intranasal | Also examined parenterally in animal work |
| Reported plasma half-life | Minutes to tens of minutes | Values vary widely between reports |
| Main model systems | Rodent behavioural and cell assays | Human trials are few and small |
| Principal proposed targets | GABA-A receptor, GABA transaminase | Monoamine and neurotrophic pathways also reported |
| Evidence grade | Preliminary | Limited independent replication |
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed as a stabilized analogue of tuftsin, a naturally occurring tetrapeptide fragment derived from the immunoglobulin heavy chain. The additional Pro-Gly-Pro segment at the carboxyl terminus is intended to slow enzymatic cleavage. The compound is usually described in the literature as a synthetic peptide with anxiolytic and cognitive-related activity, a label that reflects a research context rather than an approved therapeutic category.
Most published work on selank originates from a small number of research groups in the Russian Federation. A large share of that record appears in Russian-language journals, which limits access for readers who rely on English-indexed databases. Independent replication by laboratories outside the original research network is sparse in publicly available sources. This concentration of origin and language is a frequently noted feature when the compound is summarized in broader reviews of synthetic peptides.
Reported pharmacological effects center on reduced anxiety-like behavior in animal models and on measures of memory and learning. Proposed contributing mechanisms include modulation of GABAergic signaling, shifts in monoamine turnover, and changes in the activity of enzymes that degrade neuropeptides. Effects on the expression of genes linked to neuroplasticity have also been described. No single molecular target is widely accepted, and whether the behavioral findings arise from one pathway or several remains an open question.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, frequently abbreviated as TKPRPGP. It was designed as a structural analogue of tuftsin, a naturally occurring tetrapeptide released by enzymatic cleavage of the immunoglobulin heavy chain. The two additional proline residues at the C-terminal end extend the parent chain and change how the molecule behaves in solution. The free peptide has a calculated molecular mass of approximately 751.9 g/mol and is generally supplied as a lyophilised white to off-white powder.
Development work on the compound began in the 1980s and 1990s at the Institute of Molecular Genetics in Moscow, within the same research programme that produced the peptide Semax. Early investigators sought a tuftsin derivative with improved resistance to enzymatic breakdown and with activity in the central nervous system after peripheral administration. Most of the primary literature from this period was published in Russian, a factor that still shapes how easily the findings can be checked by outside groups.
4-Hydroxyatomoxetine, the major active metabolite of atomoxetine in CYP2D6 extensive metabolizers, has been found to have sub-micromolar affinity for opioid receptors, acting as an antagonist at the μ-opioid receptor (MOR) and as a partial agonist at the κ-opioid receptor (KOR). The affinities (IC50Tooltip half-maximal inhibitory concentration) of 4-hydroxyatomoxetine were 164 nM for the MOR, 88 nM for the KOR, 1,490 nM for the δ-opioid receptor (DOR), and >5,000 nM for the nociceptin receptor (ORL-1). Atomoxetine itself showed dramatically lower affinities (e.g., 25- to 50-fold). It is not known whether the actions of 4-hydroxyatomoxetine at the opioid receptors leads to CNS-related adverse effects with atomoxetine. Atomoxetine does not alter locomotor activity in rodents, in contrast to stimulants like amphetamine. In addition, atomoxetine does not produce self-administration in monkeys, also in contrast to stimulants like amphetamine. The drug does not produce stimulant-like effects, euphoria, or reinforcing effects in humans, instead increasing negative and unpleasant ratings at the highest assessed doses. Atomoxetine has been found to increase cortisol levels in humans.
=== Resistance === Bacteria that show no clinically relevant response to ertapenem include methicillin-resistant Staphylococcus species (including MRSA) as well as Acinetobacter, Aeromonas, Enterococcus, and Pseudomonas. Microorganisms can become resistant to ertapenem by producing carbapenemases, enzymes that inactivate the drug by opening the beta-lactam ring. Other mechanisms of resistance against carbapenems are development of efflux pumps that transport the antibiotics out of the bacterial cells, mutations of PBPs, and mutations of Gram-negative bacteria's porins which are necessary for carbapenems to enter the bacteria.
What will happen after we enter to dispute interests of all kinds?""Peruvians are very funny, they have usurped two provinces from us (referring to Jaén and Maynas); four from Buenos Aires (referring to the provinces of Upper Peru) and they dispute Chiloé with Chile, and then they are afraid that they will be conquered, because the thief is always afraid of justice.""At this moment I just learned that in the [Colombian] Congress there are good opinions regarding Upper Peru. I call good those who are inclined not to deliver it to Peru, because that is the basis of our public right"It was even denounced that Bolivar had a final project to provoke a Total Dismemberment of Peru, because the opposition of the Peruvians to his political projects was latent and exaggeratedly feared by Bolívar, therefore, to dominate the Americas, he had a duty to further weaken Peru, being necessary to take away its hegemonic possibility against the neighboring republics in South America, so that he, as president for Life (with the right to name an heir), would rule over all and thus begin the Project of a Hispano-American Confederation (led by Gran Colombia after convoking the Congress of Panama), through the weakening of the Peruvian institutional framework for such purposes. So, he wanted a Federation of the Andes, which would unify Venezuela, Colombia, and Quito (later called Ecuador) with Peru and Bolivia, leaving Bolívar as president for life.
Sources: en.wikipedia.org
Sales were legalized in Colorado in March 2015. On 25 March 2015, alcohol wholesalers and distributors in the state of Maryland announced an agreement to voluntarily ban the distribution and sale of powdered alcohol. Concerns included the potential for misuse by minors, the ease of using the powder to bring alcohol into public events or to spike drinks, and the potential to snort the powder. At the same time, a bill to ban Palcohol for one year was under consideration in the Maryland House of Delegates. In September 2015, the New Hampshire Liquor Commission banned the sale of Palcohol. By November 2015, most states had introduced legislation and laws to regulate or ban powdered alcohol. Twenty-seven have banned powdered alcohol, 2 more have placed temporary 1-year bans on the product and 3 have included powdered alcohol under their statutory definitions of alcohol meaning that it is covered by existing alcohol regulations.
Fasting, whether it be a planned fast or overnight fast, as there is a long period of time without glucose intake Exercising more than usual as it leads to more use of glucose, especially by the muscles Drinking alcohol, especially when combined with diabetic medications, as alcohol inhibits glucose production Kidney disease, as insulin cannot be cleared out of circulation well
=== Female pubertal development === Estrogens are responsible for the development of female secondary sexual characteristics during puberty, including breast development, widening of the hips, and female fat distribution. Conversely, androgens are responsible for pubic and body hair growth, as well as acne and axillary odor.
Sources: en.wikipedia.org
=== Starting material === PMCA was originally based on the normal prion protein (PrPC) from healthy brain tissue, which is expensive. The advent of recombinant proteins have lower the cost somewhat, but the steps required to obtain the pure protein are laborious. In 2011, it was found that simply putting a prion protein transgene into a cell line and then lysing the cell without purification is enough. This is expected to make PMCA much cheaper. The cell line does not need to be of a neuronal origin. PMCA is most easily performed with catalysts which are abundant even in healthy cells: a polyanion (single-stranded RNA or sulfated glycans) and a phospholipid. A cell lysate would provide both of these catalysts and most clumps of PrPSc contain catalyst polyanion molecules anyways. Synthetic versions of these catalysts such as poly(A) RNA and 1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) also work for propagating PrPSc. Additional required materials include buffer salts and detergent.
== April 1942-May 1943 == The division was assigned to XXXXVIII Panzer Corps during the opening phases of Fall Blau (Case Blue), the Wehrmacht's 1942 strategic summer offensive in southern Russia. During the combined Soviet winter offensives Operation Uranus and Operation Mars in late November through mid-December, the division fought near Rzhev, where it was rendered combat ineffective. Called upon to deal with one crisis after another, the division came to be known as die Feuerwehr (the Fire Brigade). By 18 November 1942, the division only had seven Panzer II light tanks, one Panzer III and nineteen Panzer IV medium tanks, and three Sd.Kfz. 265 Panzerbefehlswagen command tanks operational. In January–February 1943, Großdeutschland and XXXXVIII Panzer Corps, along with the II SS Panzer Corps took part in the Third Battle of Kharkov. The division had 5 Panzer IIs, 20 Panzer IIIs, 85 Panzer IVs, 9 Tiger I heavy tanks, 2 Panzerbefehlswagens, and 26 Flammpanzer III flamethrower tank variants of the Panzer III available at that time. The division fought alongside the 1. SS Division Leibstandarte SS Adolf Hitler, 2. SS Division Das Reich and 3. SS Division Totenkopf during these battles. The division's losses as total write-offs at that time amounted to one Panzer III, twelve Panzer IVs, and one Tiger I. After the capture of Kharkov, the Großdeutschland was again pulled back and refitted.
== Life and education == Christian Hackenberger grew up in Damme. He attended the Gymnasium Damme, where he obtained his Abitur in 1995. After completing his civil service, he studied chemistry at the Albert-Ludwigs-Universität in Freiburg (1996–1998) and the University of Wisconsin-Madison (M.S. with Samuel H. Gellman, 1998–1999), with support from the German Academic Scholarship Foundation. He pursued his doctoral studies at the RTWH Aachen (2000–2003), where he worked under Prof. Carsten Bolm as a Kekulé Fellow from the Fonds der Chemischen Industrie. During this time, he also worked as an editorial assistant in scientific journalism for the WDR broadcast "Quarks & Co". From 2003 to 2005 he was a DAAD Postdoctoral Fellow at the Massachusetts Institute of Technology under Prof. Barbara Imperiali. In 2005, Hackenberger founded his own research group at the Free University of Berlin in 2005 as an Emmy Noether Fellow. In 2011, he was appointed as W2 Professor of Bioorganic Chemistry at the Free University of Berlin as the first Plus 3 awardee from the Boehringer Ingelheim Foundation. In 2012, he became Leibniz-Humboldt Professor for Chemical Biology at the Leibniz Research Institute for Molecular Pharmacology and the Humboldt University of Berlin. In 2020, Hackenberger co-founded the Munich-based biotechnology company Tubulis, which specializes in developing antibody-drug conjugates. He has served as associate editor of the Royal Society of Chemistry's scientific journals Organic and Biomolecular Chemistry (2015–2023) and Chemical Science (since 2024).
Sources: en.wikipedia.org
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.
The peptide enters plasma rapidly and is broken down by ordinary proteases into amino acids and shorter fragments. Reported half-lives are short. Whether meaningful amounts of the intact molecule reach the brain is an open question.
Most clinical reports are small, published in Russian and not independently replicated. English-language reviews highlight the absence of large randomised trials. Conclusions about efficacy should be treated as provisional.
Identity is confirmed by matching the retention time in reversed-phase chromatography against a reference standard and by measuring the molecular mass with mass spectrometry. Tandem mass spectrometry or amino acid analysis can verify the sequence of the seven residues. Because the peptide contains no aromatic amino acids, detection at 280 nm is not useful.